Author： Paul Friedemann Veauthier Christian
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.6, 2012-04, pp. : 791-793
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Therapeutic developments in multiple sclerosis
By Goodin D.S.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. :
Access to resources
Recommend
Management of Fatigue in Patients with Multiple Sclerosis
By Zifko U.A.
Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. :
Novel therapeutic agents for multiple sclerosis
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. :
Fatigue in Multiple Sclerosis: Definition, Pathophysiology and Treatment
By Krupp L.B.
CNS Drugs, Vol. 17, Iss. 4, 2003-01 ,pp. :